West China Hospital
Clinical trials sponsored by West China Hospital, explained in plain language.
-
New combo therapy for head and neck cancer tested, but study pulled
Disease control TerminatedThis study aimed to see if adding low-dose radiation to a targeted-immunotherapy drug combination before surgery could improve outcomes for people with head and neck cancer. It planned to compare the combination against the drug combo alone. The study was withdrawn before enrolli…
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 26, 2026 06:31 UTC
-
New immune therapy targets EBV-Linked cancers in early trial
Disease control OngoingThis early-phase study tests a new immune-based treatment for people with advanced tumors linked to the Epstein-Barr virus (EBV) who have not responded to standard therapies. The main goal is to check the treatment's safety in 6 adults aged 18 to 70. Researchers will also look fo…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 26, 2026 06:23 UTC
-
Experimental DMD infusion: first safety check in just 3 boys
Disease control OngoingThis early-stage study tests a single intravenous dose of JWK007 in 3 boys aged 5-10 with Duchenne muscular dystrophy (DMD). The main goal is to check safety and side effects, while also looking at whether it helps muscle function. It is a very small, first-in-human trial, so it …
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 26, 2026 06:16 UTC
-
Gut bacteria boosts cancer fight? new trial tests probiotic combo
Disease control OngoingThis early-stage study tests whether a probiotic called Akkermansia, taken with an immunotherapy drug, is safe for people with advanced colorectal cancer that hasn't responded to standard treatments. The trial involves 22 participants and will monitor side effects, tumor response…
Phase: NA • Sponsor: West China Hospital • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
New drug duo aims to shrink esophageal tumors before surgery
Disease control OngoingThis early-phase trial tests whether combining two drugs, camrelizumab and palbociclib, is safe and feasible for patients with a type of esophageal cancer that can be surgically removed. The drugs are given before surgery to try to shrink the tumor. The study involves 6 participa…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Seaweed extract may soothe radiation mouth pain in cancer patients
Symptom relief OngoingThis study tests whether a spirulina-based product can prevent or treat severe mouth sores in 70 people with head and neck cancer who are getting radiation therapy. Participants will use the product during treatment to see if it reduces pain and helps them eat normally. The goal …
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Symptom relief
Last updated May 26, 2026 06:16 UTC
-
300 women studied to uncover why breast implants harden after cancer surgery
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 300 women who had immediate breast reconstruction with implants after mastectomy for breast cancer. Researchers want to understand why some women develop capsular contracture, a condition where scar tissue tightens around the implant, causing hardness or pain. …
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 06:26 UTC
-
Neurology residents test gamified learning with High-Tech wristbands and digital badges
Knowledge-focused OngoingThis study compares a new game-based teaching method to traditional lectures for neurology residents. 240 residents will attend eight sessions, wearing wristbands that measure stress and attention. They will also earn digital badges for achievements. The goal is to see if the gam…
Phase: NA • Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 04:37 UTC
-
Which drug first? study seeks optimal sequence for neuroendocrine tumor therapy
Knowledge-focused OngoingThis study looks at 500 people with advanced neuroendocrine tumors to see which order of two treatments works best: starting with surufatinib then somatostatin analogs, or the reverse. Researchers will track how long the cancer stays under control and any side effects. The goal i…
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC